Rare Diseases and Orphan Drugs
The focus on rare diseases is growing, with advancements in orphan drug development and genetic diagnostics. This session will discuss challenges in early diagnosis, regulatory hurdles, and the role of patient advocacy in shaping research priorities for rare conditions.
Sub tracks:
- Rare Disease Registries
- Genetic Testing
- Orphan Drug Development
- Innovative Therapies
- Patient Advocacy